Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan · Delayed Price · Currency is TWD 31.65
-0.25 (-0.78%)
Jul 25, 2025, 9:59 AM CST
TPEX:4111 Revenue
Chi Sheng Pharma & Biotech had revenue of 319.61M TWD in the quarter ending March 31, 2025, with 19.61% growth. This brings the company's revenue in the last twelve months to 1.22B, up 14.36% year-over-year. In the year 2024, Chi Sheng Pharma & Biotech had annual revenue of 1.17B with 9.86% growth.
Revenue (ttm)
1.22B
Revenue Growth
+14.36%
P/S Ratio
1.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.17B | 104.57M | 9.86% |
| Dec 31, 2023 | 1.06B | -82.21M | -7.19% |
| Dec 31, 2022 | 1.14B | 120.78M | 11.81% |
| Dec 31, 2021 | 1.02B | 42.94M | 4.38% |
| Dec 31, 2020 | 979.36M | -43.60M | -4.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.69B |